Inogen Inc INGN

About Inogen Inc (INGN): stock profile, AI score and financials

Inogen Inc (INGN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INGN at 33.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,383 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (18.4) and free cash flow (24.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Inogen Inc reports quarterly revenue of $95.1M, net income of $-3.9M, an operating margin of -5.4%. INGN trades on the Nasdaq exchange and files with the SEC under CIK 1294133. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Inogen Inc directly from SEC EDGAR.

SEC EDGAR: CIK 1294133 →